2025-09-09 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc. (UNH) based on the data you provided, presented in a structured format with key numbers and analysis:

## UNH (UnitedHealth Group Inc.) Analysis

**Company Overview:** UnitedHealth Group Inc. is a diversified health care company providing a wide range of health benefits and services.

### 1. Relative Performance Analysis

*   **Cumulative Return:** UNH: 20.96%, S&P 500 (VOO): 101.31%
*   **Absolute Deviation:** -80.35% (UNH is lagging S&P 500 significantly)
*   **Relative Deviation:** 13.5 (Indicates UNH's current underperformance is near the lower end of its historical range relative to the S&P 500.)

**Analysis:** UNH has significantly underperformed the S&P 500. The relative deviation suggests this underperformance is not unprecedented within its historical context, but still concerning.

### 2. Alpha, Beta Analysis

| Year       | CAGR    | MDD    | Alpha  | Beta  | Cap(B) |
| ---------- | ------- | ------- | ------ | ----- | ------ |
| 2015-2017  | 65.0%   | 56.6%   | 36.0%  | 0.0   | 202.7  |
| 2016-2018  | 52.0%   | 63.7%   | 34.0%  | 0.0   | 229.1  |
| 2017-2019  | 38.0%   | 63.7%   | 9.0%   | 0.3   | 270.4  |
| 2018-2020  | -21.0%  | 63.7%   | -40.0% | 0.4   | 322.5  |
| 2019-2021  | 36.0%   | 61.0%   | -13.0% | 0.4   | 461.8  |
| 2020-2022  | 28.0%   | 66.9%   | 26.0%  | 0.4   | 487.6  |
| 2021-2023  | 33.0%   | 67.5%   | 15.0%  | 0.4   | 484.2  |
| 2022-2024  | -31.0%  | 68.6%   | -57.0% | 0.3   | 465.2  |
| 2023-2025  | -55.0%  | 75.7%   | -108.0% | 0.1   | 290.0  |

**Analysis:**

*   **CAGR:** Significant volatility in annual growth. Recent years (2022-2025 & 2023-2025) show substantial negative growth.
*   **MDD:** Consistently high Maximum Drawdown, indicating significant risk.
*   **Alpha:**  Positive in some periods, strongly negative recently. This suggests UNH's underperformance is due to company-specific factors, not just market movements.
*   **Beta:** Generally low, indicating UNH is less sensitive to overall market movements.

### 3. Recent Price Action

*   **Current Price:** 315.39
*   **Last Market Price:** 320.25 (Previous Close: 315.39, Change: +1.54%)
*   **5-Day MA:** 309.75
*   **20-Day MA:** 294.79
*   **60-Day MA:** 291.84

**Analysis:**

*   The stock price has recently increased (positive change of 1.54%), and is above all three moving averages, indicating a short-term upward trend. The increasing price, especially given the relatively large "change," suggests a possible recent positive catalyst.
*   5일, 20일, 60일 이동평균선이 모두 상승하고 있어서 단기적 상승 추세가 강하게 나타나고 있습니다.

### 4. Technical Indicators and Outlook

*   **MRI:** 0.33 (Low Risk)
*   **RSI:** 60.33 (Approaching overbought territory)
*   **PPO:** 0.68
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Delta_Previous_Relative_Divergence (20-day):** 4.0 (+) (Short-term Increase)
*   **Expected Return:** 49.6% (Long-term, vs. S&P 500)

**Analysis:**

*   The MRI indicates relatively low market risk.
*   The RSI suggests the stock is approaching overbought territory.
*   The positive PPO confirms the recent upward momentum.
*   The Hybrid Signal suggests a cautious buy signal.
*   The positive change in relative divergence signals short-term upward momentum.
*   The high expected return suggests potential for long-term outperformance *if* the company can turn around its recent underperformance.

### 5. Recent News & Significant Events

*   **Sector Update:**  Mixed signals regarding the Health Care sector (some softness).
*   **UnitedHealth Guidance:** Reaffirming 2025 Adjusted EPS outlook, which is positive.
*   **AI Integration:**  Focus on leveraging AI for healthcare efficiency.
*   **Analyst Upgrades:** Barclays lifting its price target.
*   **Berkshire Hathaway Investment:**  Warren Buffett's Berkshire Hathaway buying shares.

**Analysis:**

*   The news is generally positive, with reaffirmation of guidance, analyst upgrades, and a significant investment from Berkshire Hathaway. These could be contributing factors to the recent price increase.
*   AI를 이용한 의료 효율성 개선에 대한 기대감이 주가에 긍정적인 영향을 미치고 있습니다.
*   Berkshire Hathaway의 투자는 투자 심리를 개선하는 데 기여하고 있습니다.

### 6. Analyst Opinions

*   **Consensus:** Buy (Mean: 1.92)
*   **Target Price:** Average: 330.08, High: 626.00, Low: 198.00

**Analysis:**

*   Analyst consensus is positive ("Buy").
*   The average target price suggests potential upside. The wide range in target prices indicates uncertainty.

### 7. Recent Earnings Analysis

| Date       | EPS   | Revenue    |
| ---------- | ----- | ---------- |
| 2025-08-11 | 3.76  | 111.62 B$ |
| 2025-05-07 | 6.9   | 109.58 B$ |
| 2024-11-04 | 6.56  | 100.82 B$ |
| 2024-08-09 | 4.58  | 98.86 B$ |
| 2025-08-11 | 4.58  | 98.86 B$ |

**Analysis:**

*   Revenue is generally trending upward. EPS is fluctuating.
*   최근 매출은 증가 추세에 있지만, EPS는 변동성이 큽니다.

### 8. Financial Information:

Revenue and Profitability:

| Quarter    | Revenue    | Profit Margin |
| ---------- | ---------- | ------------- |
| 2025-06-30 | \$111.62B | 17.93%        |
| 2025-03-31 | \$109.58B | 21.70%        |
| 2024-12-31 | \$100.81B | 21.14%        |
| 2024-09-30 | \$100.82B | 22.84%        |
| 2024-06-30 | \$98.86B  | 22.31%        |

Capital and Profitability:

| Quarter    | Equity     | ROE   |
| ---------- | ---------- | ----- |
| 2025-06-30 | \$94.72B  | 3.60% |
| 2025-03-31 | \$95.04B  | 6.62% |
| 2024-12-31 | \$92.66B  | 5.98% |
| 2024-09-30 | \$94.53B  | 6.41% |
| 2024-06-30 | \$89.36B  | 4.72% |

**Analysis:**

*   **Revenue:**  Shows a clear upward trend, indicating growth in the company's topline.
*   **Profit Margin:** Has decreased significantly in the most recent quarter, suggesting increasing costs or pricing pressures.
*   **Equity:**  Relatively stable.
*   **ROE:**  Declined significantly in the most recent quarter, consistent with the lower profit margin.

### 9. 종합적인 분석 (Overall Analysis)

*   **Negative Factors:** UNH has significantly underperformed the S&P 500 recently. The alpha and CAGR figures confirm significant challenges in recent years. Declining profit margins and ROE are concerning.
*   **Positive Factors:** Recent price momentum, positive news flow (analyst upgrades, Berkshire Hathaway investment, reaffirmation of guidance), and a "Buy" consensus from analysts. The company is actively pursuing growth opportunities (AI).
*   **Overall:** UNH presents a mixed picture. While the long-term expected return is attractive, the recent underperformance and declining profitability metrics are significant concerns. The recent positive news and price action may indicate a potential turnaround, but further monitoring is warranted. The investment from Berkshire Hathaway could be a significant vote of confidence.

**Recommendation:**

Given the conflicting signals, a cautious approach is recommended. Monitoring future earnings reports and financial metrics for signs of improvement in profitability is crucial. Investors should carefully weigh the potential upside against the risks associated with recent underperformance.
